Skip to main content
Intermediate Technical In the Industry Vocabulary Test

refractory epilepsy

Pronunciation: re-FRAK-tor-ee

Epilepsy that fails to respond to adequate trials of two or more appropriately chosen antiepileptic drugs, also called drug-resistant epilepsy.

Full Definition

Refractory epilepsy, also known as drug-resistant or pharmacoresistant epilepsy, is defined as failure to achieve sustained seizure freedom despite adequate trials of two or more well-tolerated, appropriately chosen antiepileptic drug regimens. This condition affects approximately 30% of children with epilepsy and represents a significant clinical challenge requiring specialized management approaches. Patients with refractory epilepsy may be candidates for alternative treatments including epilepsy surgery, neurostimulation devices, dietary therapies, or investigational treatments. Early identification of drug resistance is important because continued seizures can impact cognitive development, quality of life, and long-term outcomes in pediatric patients. The definition emphasizes that drug trials must be appropriate for the seizure type and syndrome.

Usage

Usage note: Modern preference is for 'drug-resistant epilepsy' over 'refractory' in formal literature, though both terms are acceptable.

In Context

  • "The child's refractory epilepsy warranted evaluation for surgical intervention." — Surgical referral note
  • "Refractory epilepsy in this patient led to consideration of vagus nerve stimulation therapy." — Treatment planning discussion

Also known as

drug-resistant epilepsy pharmacoresistant epilepsy intractable epilepsy

Contrasted with

well-controlled epilepsy responsive epilepsy

Don't confuse with

breakthrough seizures poorly compliant patient

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON